Literature DB >> 22158200

Primary aldosteronism in 2011: Towards a better understanding of causation and consequences.

Michael Stowasser1.   

Abstract

With primary aldosteronism now widely acknowledged as common and associated with both hypertension-related and non-hypertension-related pathology, research interest into its causes and consequences continues to grow. In 2011, major breakthroughs occurred in understanding the role and nature of underlying genetic disturbances and elucidating the pathophysiology of its cardiovascular sequelae.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158200     DOI: 10.1038/nrendo.2011.223

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  10 in total

1.  Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study.

Authors:  Eduardo Pimenta; Richard D Gordon; Ashraf H Ahmed; Diane Cowley; Rodel Leano; Thomas H Marwick; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2011-06-01       Impact factor: 5.958

2.  Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis.

Authors:  R D Gordon; S M Hamlet; T J Tunny; S A Klemm
Journal:  Clin Exp Pharmacol Physiol       Date:  1987-03       Impact factor: 2.557

3.  Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase.

Authors:  R P Lifton; R G Dluhy; M Powers; G M Rich; M Gutkin; F Fallo; J R Gill; L Feld; A Ganguly; J C Laidlaw
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

4.  Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis.

Authors:  Vin-Cent Wu; Shyh-Chyi Lo; Yuh-Lien Chen; Po-Hsun Huang; Chia-Ti Tsai; Chan-Jung Liang; Chin-Chi Kuo; Yih-Shing Kuo; Bai-Chin Lee; En-Ling Wu; Yen-Hung Lin; Yun-Yu Sun; Shuei-Liong Lin; Jaw-Wen Chen; Shing-Jong Lin; Kwan-Dun Wu
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

5.  Familial or genetic primary aldosteronism and Gordon syndrome.

Authors:  Michael Stowasser; Eduardo Pimenta; Richard D Gordon
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

6.  Histological and biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin.

Authors:  T J Tunny; R D Gordon; S A Klemm; D Cohn
Journal:  Clin Endocrinol (Oxf)       Date:  1991-05       Impact factor: 3.478

7.  Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms).

Authors:  Paolo Mulatero; Davide Tizzani; Andrea Viola; Chiara Bertello; Silvia Monticone; Giulio Mengozzi; Domenica Schiavone; Tracy Ann Williams; Silvia Einaudi; Antonio La Grotta; Franco Rabbia; Franco Veglio
Journal:  Hypertension       Date:  2011-08-29       Impact factor: 10.190

8.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

9.  Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.

Authors:  D J Sutherland; J L Ruse; J C Laidlaw
Journal:  Can Med Assoc J       Date:  1966-11-26       Impact factor: 8.262

10.  A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.

Authors:  David S Geller; Junhui Zhang; Max V Wisgerhof; Cedric Shackleton; Michael Kashgarian; Richard P Lifton
Journal:  J Clin Endocrinol Metab       Date:  2008-05-27       Impact factor: 5.958

  10 in total
  5 in total

Review 1.  Surgical management of adrenocortical tumours.

Authors:  Barbra S Miller; Gerard M Doherty
Journal:  Nat Rev Endocrinol       Date:  2014-03-18       Impact factor: 43.330

2.  A Bibliometric Analysis of Primary Aldosteronism Research From 2000 to 2020.

Authors:  Chengyuan Wang; Hongwei Jing; Zuyu Sun; Jiaxi Yao; Xinyu Zhang; Tao Liu; Ying Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-27       Impact factor: 5.555

3.  Radiation dose reduction during adrenal vein sampling using a new angiographic imaging technology.

Authors:  Clemens Spink; Maxim Avanesov; Alexander Lenz; Frank Oliver Henes; Lennart Well; Thomas Schmidt; Gerhard Adam; Harald Ittrich; Peter Bannas
Journal:  Sci Rep       Date:  2022-04-12       Impact factor: 4.379

4.  Primary hyperaldosteronism: challenges in subtype classification.

Authors:  Brian T Layden; Allison J Hahr; Dina M Elaraj
Journal:  BMC Res Notes       Date:  2012-10-30

5.  Radiation exposure of adrenal vein sampling: a German Multicenter Study

Authors:  C T Fuss; M Treitl; N Rayes; P Podrabsky; W K Fenske; D A Heinrich; M Reincke; T-O Petersen; M Fassnach; M Quinkler; R Kickuth; S Hahner
Journal:  Eur J Endocrinol       Date:  2018-10-01       Impact factor: 6.664

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.